Literature DB >> 34389625

Protracted yet Coordinated Differentiation of Long-Lived SARS-CoV-2-Specific CD8+ T Cells during Convalescence.

Tongcui Ma1,2, Heeju Ryu3, Matthew McGregor1,2, Benjamin Babcock4, Jason Neidleman1,2, Guorui Xie1,2, Ashley F George1,2, Julie Frouard1,2, Victoria Murray5, Gurjot Gill5, Eliver Ghosn4,6, Evan W Newell3, Sulggi A Lee7, Nadia R Roan8,2.   

Abstract

CD8+ T cells can potentiate long-lived immunity against COVID-19. We screened longitudinally-sampled convalescent human donors against SARS-CoV-2 tetramers and identified a participant with an immunodominant response against residues 322 to 311 of nucleocapsid (Nuc322-331), a peptide conserved in all variants of concern reported to date. We conducted 38-parameter cytometry by time of flight on tetramer-identified Nuc322-331-specific CD8+ T cells and on CD4+ and CD8+ T cells recognizing the entire nucleocapsid and spike proteins, and took 32 serological measurements. We discovered a coordination of the Nuc322-331-specific CD8+ T response with both the CD4+ T cell and Ab pillars of adaptive immunity. Over the approximately six month period of convalescence monitored, we observed a slow and progressive decrease in the activation state and polyfunctionality of Nuc322-331-specific CD8+ T cells, accompanied by an increase in their lymph node-homing and homeostatic proliferation potential. These results suggest that following a typical case of mild COVID-19, SARS-CoV-2-specific CD8+ T cells not only persist but continuously differentiate in a coordinated fashion well into convalescence into a state characteristic of long-lived, self-renewing memory.
Copyright © 2021 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 34389625      PMCID: PMC8763019          DOI: 10.4049/jimmunol.2100465

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  Antigen-specific memory in B-1a and its relationship to natural immunity.

Authors:  Yang Yang; Eliver Eid Bou Ghosn; Leah E Cole; Tetyana V Obukhanych; Patricia Sadate-Ngatchou; Stefanie N Vogel; Leonard A Herzenberg; Leonore A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-14       Impact factor: 11.205

2.  Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells.

Authors:  Isabel Schulien; Janine Kemming; Valerie Oberhardt; Katharina Wild; Lea M Seidel; Saskia Killmer; Franziska Daul; Marilyn Salvat Lago; Annegrit Decker; Hendrik Luxenburger; Benedikt Binder; Dominik Bettinger; Oezlem Sogukpinar; Siegbert Rieg; Marcus Panning; Daniela Huzly; Martin Schwemmle; Georg Kochs; Cornelius F Waller; Alexandra Nieters; Daniel Duerschmied; Florian Emmerich; Henrik E Mei; Axel Ronald Schulz; Sian Llewellyn-Lacey; David A Price; Tobias Boettler; Bertram Bengsch; Robert Thimme; Maike Hofmann; Christoph Neumann-Haefelin
Journal:  Nat Med       Date:  2020-11-12       Impact factor: 53.440

3.  SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.

Authors:  Julian Braun; Lucie Loyal; Marco Frentsch; Daniel Wendisch; Philipp Georg; Florian Kurth; Stefan Hippenstiel; Manuela Dingeldey; Beate Kruse; Florent Fauchere; Emre Baysal; Maike Mangold; Larissa Henze; Roland Lauster; Marcus A Mall; Kirsten Beyer; Jobst Röhmel; Sebastian Voigt; Jürgen Schmitz; Stefan Miltenyi; Ilja Demuth; Marcel A Müller; Andreas Hocke; Martin Witzenrath; Norbert Suttorp; Florian Kern; Ulf Reimer; Holger Wenschuh; Christian Drosten; Victor M Corman; Claudia Giesecke-Thiel; Leif Erik Sander; Andreas Thiel
Journal:  Nature       Date:  2020-07-29       Impact factor: 49.962

4.  Combinatorial tetramer staining and mass cytometry analysis facilitate T-cell epitope mapping and characterization.

Authors:  Evan W Newell; Natalia Sigal; Nitya Nair; Brian A Kidd; Harry B Greenberg; Mark M Davis
Journal:  Nat Biotechnol       Date:  2013-06-09       Impact factor: 54.908

5.  Evolution of antibody immunity to SARS-CoV-2.

Authors:  Christian Gaebler; Zijun Wang; Julio C C Lorenzi; Frauke Muecksch; Shlomo Finkin; Minami Tokuyama; Alice Cho; Mila Jankovic; Dennis Schaefer-Babajew; Thiago Y Oliveira; Melissa Cipolla; Charlotte Viant; Christopher O Barnes; Yaron Bram; Gaëlle Breton; Thomas Hägglöf; Pilar Mendoza; Arlene Hurley; Martina Turroja; Kristie Gordon; Katrina G Millard; Victor Ramos; Fabian Schmidt; Yiska Weisblum; Divya Jha; Michael Tankelevich; Gustavo Martinez-Delgado; Jim Yee; Roshni Patel; Juan Dizon; Cecille Unson-O'Brien; Irina Shimeliovich; Davide F Robbiani; Zhen Zhao; Anna Gazumyan; Robert E Schwartz; Theodora Hatziioannou; Pamela J Bjorkman; Saurabh Mehandru; Paul D Bieniasz; Marina Caskey; Michel C Nussenzweig
Journal:  Nature       Date:  2021-01-18       Impact factor: 69.504

6.  Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection.

Authors:  Jianmin Zuo; Alexander C Dowell; Hayden Pearce; Kriti Verma; Heather M Long; Jusnara Begum; Felicity Aiano; Zahin Amin-Chowdhury; Katja Hoschler; Tim Brooks; Stephen Taylor; Jacqueline Hewson; Bassam Hallis; Lorrain Stapley; Ray Borrow; Ezra Linley; Shazaad Ahmad; Ben Parker; Alex Horsley; Gayatri Amirthalingam; Kevin Brown; Mary E Ramsay; Shamez Ladhani; Paul Moss
Journal:  Nat Immunol       Date:  2021-03-05       Impact factor: 25.606

7.  CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity.

Authors:  Thi H O Nguyen; Louise C Rowntree; Jan Petersen; Brendon Y Chua; Luca Hensen; Lukasz Kedzierski; Carolien E van de Sandt; Priyanka Chaurasia; Hyon-Xhi Tan; Jennifer R Habel; Wuji Zhang; Lilith F Allen; Linda Earnest; Kai Yan Mak; Jennifer A Juno; Kathleen Wragg; Francesca L Mordant; Fatima Amanat; Florian Krammer; Nicole A Mifsud; Denise L Doolan; Katie L Flanagan; Sabrina Sonda; Jasveen Kaur; Linda M Wakim; Glen P Westall; Fiona James; Effie Mouhtouris; Claire L Gordon; Natasha E Holmes; Olivia C Smibert; Jason A Trubiano; Allen C Cheng; Peter Harcourt; Patrick Clifton; Jeremy Chase Crawford; Paul G Thomas; Adam K Wheatley; Stephen J Kent; Jamie Rossjohn; Joseph Torresi; Katherine Kedzierska
Journal:  Immunity       Date:  2021-04-15       Impact factor: 31.745

8.  Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.

Authors:  Alba Grifoni; Daniela Weiskopf; Sydney I Ramirez; Jose Mateus; Jennifer M Dan; Carolyn Rydyznski Moderbacher; Stephen A Rawlings; Aaron Sutherland; Lakshmanane Premkumar; Ramesh S Jadi; Daniel Marrama; Aravinda M de Silva; April Frazier; Aaron F Carlin; Jason A Greenbaum; Bjoern Peters; Florian Krammer; Davey M Smith; Shane Crotty; Alessandro Sette
Journal:  Cell       Date:  2020-05-20       Impact factor: 66.850

9.  Suboptimal SARS-CoV-2-specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotype.

Authors:  Jennifer R Habel; Thi H O Nguyen; Carolien E van de Sandt; Jennifer A Juno; Priyanka Chaurasia; Kathleen Wragg; Marios Koutsakos; Luca Hensen; Xiaoxiao Jia; Brendon Chua; Wuji Zhang; Hyon-Xhi Tan; Katie L Flanagan; Denise L Doolan; Joseph Torresi; Weisan Chen; Linda M Wakim; Allen C Cheng; Peter C Doherty; Jan Petersen; Jamie Rossjohn; Adam K Wheatley; Stephen J Kent; Louise C Rowntree; Katherine Kedzierska
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-10       Impact factor: 11.205

10.  Unbiased Screens Show CD8+ T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein.

Authors:  Andrew P Ferretti; Tomasz Kula; Yifan Wang; Dalena M V Nguyen; Adam Weinheimer; Garrett S Dunlap; Qikai Xu; Nancy Nabilsi; Candace R Perullo; Alexander W Cristofaro; Holly J Whitton; Amy Virbasius; Kenneth J Olivier; Lyndsey R Buckner; Angela T Alistar; Eric D Whitman; Sarah A Bertino; Shrikanta Chattopadhyay; Gavin MacBeath
Journal:  Immunity       Date:  2020-10-20       Impact factor: 31.745

View more
  7 in total

1.  mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.

Authors:  Jason Neidleman; Xiaoyu Luo; Matthew McGregor; Guorui Xie; Victoria Murray; Warner C Greene; Sulggi A Lee; Nadia R Roan
Journal:  Elife       Date:  2021-10-12       Impact factor: 8.140

2.  Deep Phenotypic Analysis of Blood and Lymphoid T and NK Cells From HIV+ Controllers and ART-Suppressed Individuals.

Authors:  Ashley F George; Xiaoyu Luo; Jason Neidleman; Rebecca Hoh; Poonam Vohra; Reuben Thomas; Min-Gyoung Shin; Madeline J Lee; Catherine A Blish; Steven G Deeks; Warner C Greene; Sulggi A Lee; Nadia R Roan
Journal:  Front Immunol       Date:  2022-01-27       Impact factor: 8.786

3.  CD4+ T Cell Immune Specificity Changes After Vaccination in Healthy And COVID-19 Convalescent Subjects.

Authors:  Laura Esparcia-Pinedo; Pedro Martínez-Fleta; Noelia Ropero; Paula Vera-Tomé; Hugh T Reyburn; José M Casasnovas; José M Rodríguez Frade; Mar Valés-Gómez; Carlos Vilches; Enrique Martín-Gayo; Cecilia Muñoz-Calleja; Francisco Sanchez-Madrid; Arantzazu Alfranca
Journal:  Front Immunol       Date:  2022-01-19       Impact factor: 7.561

Review 4.  A Complementary Union of SARS-CoV2 Natural and Vaccine Induced Immune Responses.

Authors:  Joseph Torresi; Melissa A Edeling; Terry Nolan; Dale I Godfrey
Journal:  Front Immunol       Date:  2022-07-13       Impact factor: 8.786

Review 5.  T cells in SARS-CoV-2 infection and vaccination.

Authors:  Arthur Young
Journal:  Ther Adv Vaccines Immunother       Date:  2022-08-24

6.  Intradermal-delivered DNA vaccine induces durable immunity mediating a reduction in viral load in a rhesus macaque SARS-CoV-2 challenge model.

Authors:  Ami Patel; Jewell N Walters; Emma L Reuschel; Katherine Schultheis; Elizabeth Parzych; Ebony N Gary; Igor Maricic; Mansi Purwar; Zeena Eblimit; Susanne N Walker; Diana Guimet; Pratik Bhojnagarwala; Opeyemi S Adeniji; Arthur Doan; Ziyang Xu; Dustin Elwood; Sophia M Reeder; Laurent Pessaint; Kevin Y Kim; Anthony Cook; Neethu Chokkalingam; Brad Finneyfrock; Edgar Tello-Ruiz; Alan Dodson; Jihae Choi; Alison Generotti; John Harrison; Nicholas J Tursi; Viviane M Andrade; Yaya Dia; Faraz I Zaidi; Hanne Andersen; Mohamed Abdel-Mohsen; Mark G Lewis; Kar Muthumani; J Joseph Kim; Daniel W Kulp; Laurent M Humeau; Stephanie J Ramos; Trevor R F Smith; David B Weiner; Kate E Broderick
Journal:  Cell Rep Med       Date:  2021-09-28

7.  Dominant CD8+ T Cell Nucleocapsid Targeting in SARS-CoV-2 Infection and Broad Spike Targeting From Vaccination.

Authors:  Ellie Taus; Christian Hofmann; Francisco Javier Ibarrondo; Mary Ann Hausner; Jennifer A Fulcher; Paul Krogstad; Kathie G Ferbas; Nicole H Tobin; Anne W Rimoin; Grace M Aldrovandi; Otto O Yang
Journal:  Front Immunol       Date:  2022-02-22       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.